Top compounds associated with response to LINC00521


Feature Type Standardized
Nominal ANOVA
mRNA elocalcitol CTRPv2 pan-cancer AAC -0.033 0.3
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.033 0.3
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.033 0.3
mRNA pifithrin-mu CTRPv2 pan-cancer AAC -0.034 0.3
mRNA austocystin d CTRPv2 pan-cancer AAC 0.036 0.3
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.033 0.3
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC -0.035 0.3
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.3
mRNA L-685458 CCLE pan-cancer AAC -0.043 0.3
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.033 0.3
Download CSV